Search

Your search keyword '"Advaxis Inc. -- Intellectual property"' showing total 4 results
Start Over Descriptor "Advaxis Inc. -- Intellectual property" Publisher normans media ltd.
4 results on '"Advaxis Inc. -- Intellectual property"'

1. Advaxis Granted US Patent Relating to Axalimogene Filolisbac

Subjects
United States. Food and Drug Administration, Advaxis Inc. -- Intellectual property, Biotechnology industries -- Intellectual property, Biological products, T cells, Immunotherapy, Papillomavirus infections, Bacteria, Listeria, Cancer, Antigens, Tumors, Proteins, Chemistry
Abstract

M2 PHARMA-March 26, 2019-Advaxis Granted US Patent Relating to Axalimogene Filolisbac (C)2019 M2 COMMUNICATIONS - US-based biotechnology company Advaxis, Inc. (NASDAQ: ADXS) has granted patent number 10,189,885 titled 'Non-Hemolytic LLO [...]

Published
2019

2. Advaxis Inc receives US Notice of Allowance for patent for ADXS-HPV

Subjects
Advaxis Inc. -- Intellectual property, Biotechnology industry -- Intellectual property, Cervical cancer, Patents, Patent/copyright issue, Business
Abstract

M2 EQUITYBITES-October 19, 2011-Advaxis Inc receives US Notice of Allowance for patent for ADXS-HPV(C)2011 M2 COMMUNICATIONS http://www.m2.com Biotechnology company Advaxis Inc (OTCBB:ADXS.ob) reported on Tuesday the receipt of a Notice [...]

Published
2011

3. Advaxis Inc receives US patent for live Listeria HER2/neu immunotherapy

Subjects
Advaxis Inc. -- Intellectual property, Biotechnology industry -- Intellectual property, Immunotherapy, Patents, Patent/copyright issue, Business
Abstract

M2 EQUITYBITES-September 10, 2010-Advaxis Inc receives US patent for live Listeria HER2/neu immunotherapy(C)2010 M2 COMMUNICATIONS http://www.m2.com Biotechnology company Advaxis Inc (OTCBB: ADXS) reported on Thursday that it has been granted [...]

Published
2010

4. Advaxis Inc to receive new vaccine technology patent from USPTO

Subjects
Advaxis Inc. -- Intellectual property, Biotechnology industry -- Intellectual property, Vaccines, Patents, Patent/copyright issue, Business
Abstract

M2 EQUITYBITES-23 August 2010-Advaxis Inc to receive new vaccine technology patent from USPTO(C)2010 M2 COMMUNICATIONS http://www.m2.com Biotechnology company Advaxis Inc (OTCBB:ADXS) said on Friday that it has received notification that [...]

Published
2010

Catalog

Books, media, physical & digital resources
See catalog results